R3 Stem Cell Therapy for Parkinson’s Disease | Dr. David Greene
A progressive acute pain condition, Parkinson’s disease is a neurological condition. It affects roughly 1% of elderly adults in industrialized countries who are 60 years older. According to Dr. David Greene, both hereditary and environmental factors may be involved in the development of the disease. There is a decrease in dopamine levels in specific brain regions due to Parkinson’s disease, which results in the death of neurons. Neurotransmitters include dopamine.
